Market revenue in 2022 | USD 8,508.3 million |
Market revenue in 2030 | USD 18,017.3 million |
Growth rate | 9.8% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.62% in 2022. Horizon Databook has segmented the U.S. molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounted for the major revenue share of North America market in 2019. Increasing application of NGS technology coupled with developments in PCR tools is anticipated to positively impact the market growth. Development of technologically advanced products is also contributing to the market growth.
For instance, in May 2019, Pharmozyme, Inc. launched Crystal Taq, which is a costeffective solution with improved test accuracy. This is the first Taq Polymerase enzyme free from bacterial and animal DNA contamination.
This product reduces PCR background contamination. Furthermore, rise in government initiatives to promote precision medicine is expected to result in lucrative growth. The National Institute of Health along with various other research institutes is engaged in precision medicine initiative.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into U.S. molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account